The CBD industry could be worth more than $22 billion by 2030, according to Grand View Research, representing a blistering 16.8% compound annual growth rate. While many companies struggle to set themselves apart, one business recently made waves by partnering with one of the nation’s largest CBD distributors.

1606 Corp. (Ticker Symbol CBDW) signed a product distribution agreement with Cool Blue Distribution to represent Bio Nutrition, a CBDW brand, on a compensated, and incentivized basis. According to Brio Nutrition CEO Shannon Shell, the partnership provides Brio with the potential to increase revenue exponentially. 

In this article, we’ll look at why the distribution agreement between 1606 and Cool Blue matters to Investors, and explains what’s next for CBDW following this landmark deal.

Why It Matters

Cool Blue Distribution is one of the nation’s premier CBD suppliers, distributing some of the most recognizable CBD  brands spanning everything from pet chews to topicals, vape pens, gummies, and more. By streamlining the supply chain process for retailers, Cool Blue makes it easy for retailers to supply products that direct customers actually want while opening new revenue opportunities for CBDW. 

The landmark distribution deal comes just a month after CBDW acquired a 51% stake in Brio Nutrition, a profitable CBD development and distribution company with more than 45 new products. These products have generated more than $3,000,000 in revenue since 2019. – a figure that is anticipated to grow. 

What’s Next?

The Cool Blue Distribution deal comes as CBDW streamlines the new Brio Nutrition brand of products, and other brands under its umbrella.  In addition to retail sales, CBDW has been working on a comprehensive online strategy to take advantage of Twitter’s decision to allow CBD companies to post sponsored content on their platform.

By acquiring mature companies and leveraging synergies with their existing businesses, CBDW management aims to unlock shareholder value by building revenue of reach holding to a point where CBDW can join top CBD businesses on a national stock exchange.

In particular, over the next 24 months, the company plans to acquire CBD companies, capturing sufficient revenue to list on a higher exchange. For example, The iconic exchange, NASDAQ, has three Capital Market listing standards addressing equity, market value, or net income. The uplisting could help the company attract a broader investor base and access even more capital.

If you want to learn more, complete the form below to receive the company’s investor presentation and updates.

Disclaimer

This communication contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Read our full disclosure at: https://cfnmedia.com/legal-disclaimer/.

1606 Corp. is a client of CFN Enterprises Inc. 1606 Corp. agreed to pay CFN Enterprises Inc. $30,000 beginning on February 15, 2023, for a three-month investor awareness campaign.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up for Our Newsletter

Get the latest investment ideas and strategies sent straight to your inbox.

You May Also Like

Hempacco Welcomes Miki Stephens to Its Board of Directors

Stephens brings deep industry and corporate governance experience to Hempacco San Diego,…

PharmAla Biotech announces Non-Brokered Private Placement Offering of up to an Aggregate of $5,000,000

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2023 (GLOBE NEWSWIRE) —…

Clearmind Medicine Granted Patent Approval in Hong Kong

Vancouver, Canada, June 28, 2024  — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind”…